The sixth most common principal diagnosis, sepsis, also takes the title as the most expensive inpatient diagnosis, racking up about $20 billion in hospitals’ aggregated annual costs. Sepsis isn’t ...
New retrospective study in CHEST found procalcitonin testing at admission reduced the length of stay and total cost of care Each year, over $20 billion dollars is spent on sepsis care, making it the ...
HealthDay News — Hospital adoption of procalcitonin (PCT) testing has had little impact on antibiotic prescribing for chronic obstructive pulmonary disease (COPD) exacerbations, according to a study ...
WASHINGTON — The use of a procalcitonin (PCT) test to guide antibiotic therapy in patients with lower respiratory tract infections and sepsis is of no value without education on how to interpret the ...
A dangerous and often deadly condition, sepsis affects more than a million Americans every year and the cases continue to increase. A new study examines whether procalcitonin (PCT) testing helps to ...
A study has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time children spend on intravenous (IV) antibiotics in hospitals. Despite promising previous ...
HENNIGSDORF, Germany--(BUSINESS WIRE)--For healthcare professionals facing the complexity of daily requirements in emergency situations, a new point-of-care test, Samsung IB B·R·A·H·M·S PCT assay, ...
Procalcitonin (PCT) is a biomarker widely used to assess the risk of bacterial infection and to aid in antibiotic stewardship in patients with lower respiratory tract infections and sepsis. In this ...
LITTLE RIVER, S.C.--(BUSINESS WIRE)-- PCT LTD (OTC PINK: PCTL) provides an update relative to ongoing infield testing at the Grassy Creek, MO testing site. During the three weeks, January 7th – 21st, ...
ISLAMABAD: The Federal Board of Revenue (FBR) has directed Collectors of Customs to ensure that the products imported under newly-created Pakistan Customs Tariff (PCT) Headings are tested through a ...
A groundbreaking UK study led by the University of Liverpool has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time children spend on intravenous (IV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback